New Findings from University of Michigan Describe Advances in COVID-19 (Association Between Health Insurance Type and Adverse Outcomes for Children and Young Adults With Type 1 Diabetes and Coronavirus Disease 2019): Coronavirus – COVID-19

2023 OCT 11 (NewsRx) -- By a News Reporter-Staff News Editor at CDC & FDA Daily -- Current study results on COVID-19 have been published. According to news originating from Ann Arbor, Michigan, by NewsRx editors, the research stated, “Health insurance coverage type differs significantly by socioeconomic status and racial group in the United States. The aim of this study was to determine whether publicly insured children and young adults with type 1 diabetes were more likely to experience adverse outcomes compared with privately insured patients with acute coronavirus disease 2019 (COVID-19) infections.”

The news correspondents obtained a quote from the research from University of Michigan: “Data from 619 patients with previously established type 1 diabetes who were <24 years of age with acute COVID-19 infections were analyzed from the T1D Exchange COVID-19 surveillance registry. Data for the registry was collected from 52 endocrinology clinics across the United States using an online survey tool. Each site completed the survey using electronic health record data between April 2020 and December 2021. Of the 619 patients included in this study, 257 had public insurance, and 362 had private insurance. Of the 257 publicly insured patients with COVID-19, 57 reported severe adverse outcomes (22%), defined as diabetic ketoacidosis (DKA) or severe hypoglycemia. In comparison, there were 25 reported adverse outcomes (7%) among the 362 privately insured patients.”

According to the news reporters, the research concluded: “Our data reveal high rates of hospitalization and DKA among publicly insured racial/ethnic minority children and young adults with type 1 diabetes and COVID-19.”

For more information on this research see: Association Between Health Insurance Type and Adverse Outcomes for Children and Young Adults With Type 1 Diabetes and Coronavirus Disease 2019. Diabetes Spectrum, 2023. The publisher for Diabetes Spectrum is American Diabetes Association.

A free version of this journal article is available at https://doi.org/10.2337/ds23-0002.

Our news editors report that more information may be obtained by contacting Amy Ohmer, 4Division of Pediatric Endocrinology, University of Michigan, Ann Arbor, MI, United States. Additional authors for this research include Brian Miyazaki, Osagie Ebekozien, Saketh Rompicherla, Ines Guttman-Bauman, Andrea Mucci, Alissa Guarneri, Vandana Raman, Allison Smego, Jane K. Dickinson.

ORCID is an identifier for authors and includes bibliographic information. The following is ORCID information for the author of this research: Brian Miyazaki (http://orcid.org/0009-0009-2122-025X).

(Our reports deliver fact-based news of research and discoveries from around the world.)